Alaunos Therapeutics Inc

NASDAQ:TCRT   11:43:11 AM EDT
0.53
+0.03 (+5.82%)
Earnings Announcements

Alaunos Therapeutics Reports Q4 Results

Published: 03/30/2022 11:44 GMT
Alaunos Therapeutics Inc (TCRT) - Q4 Loss per Share $0.05.
As of December 31, 2021, Alaunos Had Approximately $76.1 Million in Cash and Cash Equivalents.
Anticipates Its Cash Runway Will Be Sufficient to Fund Operations Into Q2 of 2023.
Q4 Earnings per Share View $-0.08 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.